Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.
Please consider a small donation if you think this website provides you with relevant information
| Date | Title | Source |
|---|---|---|
| 2024-03-05 8:53:10 pm | PPBT Stock Earnings: Purple Biotech Meets EPS for Q4 2023 | InvestorPlace |
| 2024-03-05 4:55:0 am | Purple Biotech Reports Fourth Quarter and Full-Year 2023 Financial Results | GlobeNewswire |
| 2024-02-27 4:0:0 am | Purple Biotech Presents Data of its Phase 1 Head & Neck Cancer of NT219 in combination with Cetuximab at ESMO TAT Congress 2024 | GlobeNewswire |
| 2024-02-13 4:0:0 am | Purple Biotech Convenes a Head & Neck Cancer Scientific Advisory Board in Preparation for NT219 Phase 2 Trial | GlobeNewswire |
| 2024-02-01 4:30:0 am | Purple Biotech Reaches Recommended Phase 2 Dose for NT219 | GlobeNewswire |
| 2023-12-20 5:5:0 am | Purple Biotech Appoints Dr. Yael Margolin to its Board of Directors | GlobeNewswire |
| 2023-12-14 3:50:0 am | Purple Biotech Completes Patient Enrollment in Phase 2 Pancreatic Cancer Trial | GlobeNewswire |
Please consider a small donation if you think this website provides you with relevant information